Case Challenge

Management of a 65-Year-Old Male With Metastatic Colorectal Cancer and Gilbert's Syndrome

Source: Treatment Options in Colon and Rectal Cancers: The Role of Oral Therapy

Management of a 65-Year-Old Male With Metastatic Colorectal Cancer and Gilbert's Syndrome


Faculty:

Alan P. Venook, MD
  • Alan P. Venook, MD

CME CREDIT INFORMATION

Release Date: 11/02/07

Expiration Date: 11/01/08


Physicians: maximum of 0.75 AMA PRA Category 1 Credits

Status: Please log in to view status


Begin the Case Challenge

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Articulate the options for cytotoxic and targeted agents as first-line treatment of a patient with metastatic colorectal cancer and Gilbert’s syndrome
  • Describe the surgical considerations for primary tumors for a patient with metastatic colorectal cancer and Gilbert’s syndrome
  • Relate strategies for addressing treatment-induced neuropathy during administration of an oxaliplatin-based regimen for a patient with metastatic colorectal cancer and Gilbert’s syndrome

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

This program is supported by an independent educational grant from Roche.